product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
JMJD1B/JHDM2B Antibody
catalog :
2621
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunocytochemistry, immunoprecipitation, western blot knockout validation, immunohistochemistry knockout validation
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry knockout validation; mouse; loading ...; fig 1b
  • western blot knockout validation; mouse; loading ...; fig 1a
Liu Z, Oyola M, Zhou S, Chen X, Liao L, Tien J, et al. Knockout of the Histone Demethylase Kdm3b Decreases Spermatogenesis and Impairs Male Sexual Behaviors. Int J Biol Sci. 2015;11:1447-57 pubmed publisher
Liu Z, Chen X, Zhou S, Liao L, Jiang R, Xu J. The histone H3K9 demethylase Kdm3b is required for somatic growth and female reproductive function. Int J Biol Sci. 2015;11:494-507 pubmed publisher
product information
SKU :
2621S
Product-Name :
JMJD1B/JHDM2B Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
220
Host :
Rabbit
Target :
JMJD1B
Primary-Protein :
JMJD1B
Alt-Names :
5qNCA,C5orf7,JHDM2B,JMJD1B,JmjC domain-containing histone demethylation protein 2B,Jumonji domain-containing protein 1B,KDM3B,KIAA1082,Lysine-specific demethylase 3B,NET22,Nuclear protein 5qNCA,jumonji domain containing 1B,lysine (K)-specific demethylase 3B
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.